Climate-related risk and pharmaceutical market dynamics in India and USA: evidence from transfer entropy, BEKK GARCH, and coherence wavelet [0.03%]
印度和美国的气候相关风险与药品市场动态：基于转移熵、BEKK-GARCH和相干小波的证据
Yedhu Harikumar,Muthumeenakshi Muralikrishna,Prakasam Muralikrishna et al.
Yedhu Harikumar et al.
Background: Greenhouse gas emissions, especially the atmospheric trapping of carbon dioxide (CO2), are widely linked to increased weather variability, thereby affecting other aspects of human activity and nature. The incr...
Prevention, artificial intelligence, and mathematics in Health economics: a framework for dynamic value modelling under long-term uncertainty [0.03%]
预防、人工智能与数学在卫生经济学中的应用——长期不确定性下的动态价值模型框架
Lieke Maas,Ayshe Yaylali,Mickael Hiligsmann
Lieke Maas
Developing, updating and validating DepMod 2.0: an R-based decision-analytic model for the cost-effectiveness of depression interventions [0.03%]
开发、更新和验证DepMod 2.0：一种基于R的决策分析模型，用于评估抑郁症干预措施的成本效果iveness of depression interventions
Stijn B Peeters,Frederick W Thielen,Ben F M Wijnen
Stijn B Peeters
Background: Depression imposes a substantial clinical and economic burden, and evaluating the cost-effectiveness of prevention and treatment strategies is essential for informed mental health policy. The original DepMod m...
Comparative cost per responder analysis of Ciltacabtagene autoleucel and real-world standard of Care therapy in patients with lenalidomide-refractory multiple myeloma [0.03%]
塞利尤单抗与来那度胺难治多发性骨髓瘤现实世界标准治疗的个案成本比较分析研究
Doris K Hansen,Xiaoxiao Lu,Omar Castaneda Puglianini et al.
Doris K Hansen et al.
Background: Ciltacabtagene autoleucel (cilta-cel) is a chimeric antigen receptor T-cell therapy currently approved for relapsed/refractory multiple myeloma (RRMM). This study aimed to assess the value of cilta-cel against...
Impact of early-stage immunotherapy on health and work productivity in the Czech Republic, 2024-2033 [0.03%]
2024-2033年免疫治疗早期阶段对捷克共和国健康和工作生产力的影响
Gittan Blezer,Karl Patterson,Tomáš MIčoch et al.
Gittan Blezer et al.
Background: This study evaluated the health and productivity impact of expanding the use of inhibitors of programmed cell death protein 1 (PD-1) or its ligand (PD-L1), referred to as anti-PD-(L)1 agents, to early-stage ca...
Trends in antidepressant utilization, expenditure, and demographic prescribing patterns in Jordan: a retrospective analysis [0.03%]
约旦抗抑郁药利用、支出及人口统计学处方模式的回顾性分析
Safa&#x; F Al Twahya,Rima Hijazeen,Hamzeh Almomani et al.
Safa&#x; F Al Twahya et al.
Background: The psychological aftermath of the COVID-19 pandemic and ongoing regional stressors have influenced mental health needs in Jordan. Understanding antidepressant utilization and expenditure trends is essential f...
Economic and humanistic burden of chronic liver diseases in the United States [0.03%]
美国慢性肝病的经济和人文负担
Javeria Khalid,Yinan Huang,Rajender R Aparasu
Javeria Khalid
Background: Little is known about the healthcare burden of Chronic liver disease (CLD) post-introduction of newer antiviral therapies for hepatitis in the US. Therefore, this national study examined the healthcare expendi...
Health technology assessment reports for oncology medications in Canada from 2018 to 2025: methodological critiques on manufacturers' submissions and a comparison between manufacturers and Canada's drug agency (CDA) analyses [0.03%]
2018至2025年加拿大癌症药物卫生技术评估报告：对制造商提交资料的方法学批评及制造商与加拿大药品管理局分析之比较
Sepideh Mardani Jadid,Mobina Dokhaei,Naeemeh Dini et al.
Sepideh Mardani Jadid et al.
Objective: Providing an analytical framework to evaluate critiques by Canada's Drug Agency (CDA) and to compare the manufacturers' economic analyses versus CDA's reanalyses for oncology medications. ...
Cost consequence minimization and budget impact model for introducing the fully liquid combined acellular hexavalent vaccine into the Dominican Republic's expanded immunization plan [0.03%]
关于在多米尼加共和国扩大免疫计划中引入全液体制备的无细胞结合六联疫苗的成本后果最小化和预算影响模型研究
Rosa Acevedo Saladín,Sandra Orsini Peña,Pieralessandro Lasalvia
Rosa Acevedo Saladín
Background: This study evaluates the economic impact of incorporating a fully liquid combined acellular hexavalent vaccine within Expanded Program on Immunizations (EPI) of the Dominican Republic (DR). ...
Comparative cost-utility analysis of ixekizumab, tofacitinib, and golimumab in psoriatic arthritis: a real-world Markov model simulation [0.03%]
依奇珠单抗、托法替尼和戈利木单抗治疗银屑病关节炎的比较效用成本分析：真实世界的马尔可夫模型模拟
Rubén Queiro,Ignacio Braña,Paula Alvarez et al.
Rubén Queiro et al.
Background: Psoriatic arthritis (PsA) requires long-term, phenotype-oriented management. This study compared the cost-utility of ixekizumab, tofacitinib, and golimumab using a real-world modeling approach. ...